A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms
- PMID: 16854565
- DOI: 10.1016/j.schres.2006.05.022
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms
Abstract
Background: Schizophrenics exhibit deficits in prepulse inhibition (PPI) of the startle response, and have high rates of cigarette smoking. We evaluated the effects of cigarette smoking on PPI deficits in schizophrenia, and the role of nicotinic acetylcholine receptors (nAChRs) in mediating cigarette smoking-related PPI enhancement.
Methods: PPI was assessed at baseline, after overnight abstinence, and after smoking reinstatement during three separate test weeks in nicotine-dependent schizophrenia (n=15) and control (n=14) smokers pre-treated with the nAChR antagonist mecamylamine (MEC; 0.0, 5.0 or 10.0 mg/day).
Results: PPI was comparable between schizophrenia and control smokers after ad lib cigarette smoking. Overnight smoking abstinence significantly reduced PPI, while smoking reinstatement reversed abstinence-induced worsening of PPI deficits in schizophrenia. However, acute abstinence and reinstatement did not alter PPI in controls. PPI enhancement by smoking reinstatement in schizophrenia was dose-dependently blocked by MEC, whereas MEC had no effect on PPI in control smokers.
Conclusions: These results suggest that: 1) Non-deprived smokers with schizophrenia have comparable levels of PPI to non-deprived smoking controls; 2) In schizophrenia, PPI is impaired by smoking abstinence and improved by acute smoking reinstatement, and; 3) enhancement of PPI by cigarette smoking in schizophrenia is mediated by stimulation of central nAChRs. Our findings may contribute to understanding the increased vulnerability to nicotine dependence in schizophrenia, with implications for treatment of PPI deficits in this disorder.
Similar articles
-
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.Arch Gen Psychiatry. 2005 Jun;62(6):649-59. doi: 10.1001/archpsyc.62.6.649. Arch Gen Psychiatry. 2005. PMID: 15939842
-
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.Schizophr Res. 2007 Mar;91(1-3):217-25. doi: 10.1016/j.schres.2006.12.007. Epub 2007 Feb 9. Schizophr Res. 2007. PMID: 17293085 Free PMC article. Clinical Trial.
-
Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist.Schizophr Res. 2006 Jul;85(1-3):213-21. doi: 10.1016/j.schres.2006.03.025. Epub 2006 May 4. Schizophr Res. 2006. PMID: 16678390 Clinical Trial.
-
Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.Cell Mol Neurobiol. 2007 Aug;27(5):609-39. doi: 10.1007/s10571-007-9149-x. Cell Mol Neurobiol. 2007. PMID: 17554626 Free PMC article. Review.
-
Human and animal studies of schizophrenia-related gating deficits.Curr Psychiatry Rep. 1999 Oct;1(1):31-40. doi: 10.1007/s11920-999-0008-y. Curr Psychiatry Rep. 1999. PMID: 11122903 Review.
Cited by
-
A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.J Dual Diagn. 2012 Jan 1;8(2):126-130. doi: 10.1080/15504263.2012.671717. Epub 2012 May 11. J Dual Diagn. 2012. PMID: 22737046 Free PMC article.
-
Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.Schizophr Res. 2009 Dec;115(2-3):317-24. doi: 10.1016/j.schres.2009.07.019. Epub 2009 Aug 22. Schizophr Res. 2009. PMID: 19700263 Free PMC article. Clinical Trial.
-
Inhibitory learning is modulated by nicotinic acetylcholine receptors.Neuropharmacology. 2015 Feb;89:360-7. doi: 10.1016/j.neuropharm.2014.10.025. Neuropharmacology. 2015. PMID: 25445487 Free PMC article.
-
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.Biochem Pharmacol. 2015 Oct 15;97(4):388-398. doi: 10.1016/j.bcp.2015.07.027. Epub 2015 Jul 29. Biochem Pharmacol. 2015. PMID: 26231940 Free PMC article. Review.
-
Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.Neuropsychopharmacology. 2008 Aug;33(9):2167-74. doi: 10.1038/sj.npp.1301601. Epub 2007 Oct 24. Neuropsychopharmacology. 2008. PMID: 17957213 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical